![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, January 24, 2004 3:59:01 AM
http://www.dnaprint.com/pr_7_10.htm
"Researchers from both institutions will team to complete admixture mapping and candidate genome screens to identify the complex genetic determinants of variable human skin pigmentation, tanning/burn response and melanoma risk."
Next to the text you posted:
"Our work on human pigmentation genetics has provided a framework to understand normal variation in this physical trait and the associated genotypic risk for skin cancer development. The genes that determine an individual's skin phototype and the cellular mechanisms that result in the tanning response of melanocytes after UV-exposure of the skin are actively being investigated."
The synergies are readily apparent. The number of areas of overlap that there are with forensic and medical initiatives in Australia is, as others have noted before, quite intriguing.
Ming
Leglessinseattle
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM